Chen, Leslie Y. ,Ph.D.
Intitution:Linkou Chang Gung Memorial Hospital
Position:
Assistant research fellow 
Department:
Medical Research Department
Address:No.5, Fusing St., Gueishan Township, Taoyuan County 333, Taiwan (R.O.C.) 
Tel:+886-3-3281200 ext 8871
E-mail: chenyyl@gmail.com
Focus of Interest:- Cancer biology
- Pharmacogenomics
- Systems biology
- Bioinformatics
Fulltime Employment: - 2011.12-2012.11 Research Scientist at Institute for Systems Biology (Seattle, USA)
- 2008.06-2011.12 Post-doctoral Fellow at Institute for Systems Biology (Seattle, USA)
- 2007.12-2008.05 Post-doctoral Research Associate at Wellcome Trust Sanger Institute (Cambridge, United Kingdom)
Education: 》 University of Cambridge, United Kingdom
Selected Publications:- Chen LY*, Wei KC*, Huang ACY*, Wang K, Huang CY, Yi D, Tang CY, Galas, DJ, Hood LE. RNASEQR - A streamlined and accurate RNA-seq sequence analysis program. (2012) Nucl. Acids Res. 40(6): e42 (Corresponding author)
- International Warfarin Pharmacogenetics Consortium. Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups. (2010) Blood. 115(18):3827-34
- International Warfarin Pharmacogenetics Consortium. Estimation of the warfarin dose with clinical and pharmacogenetic data. (2009) N Engl J Med. 360(8):753-64
- Wadelius M*, Chen LY*, Lindh J*, Eriksson N*, Ghori J, Bumpstead S, Holm L, McGinnis R, Rane A, Deloukas P. The largest prospective warfarin-treated cohort supports genetic forecasting. (2009) Blood. 113(4):784-92. *Co-first authors (“Must read” by the Faculty of 1000 Medicine)
- Wadelius M, Chen LY, Eriksson N, Bumpstead S, Ghori J, Wadelius C, Bentley D, McGinnis R, Deloukas P. (2007) Association of warfarin dose with genes involved in its action and metabolism. Hum Genet. 121:23-34
Full Publication List
Board Certification:1.International Warfarin Pharmacogenomics Consortium
Ongoing projects:Comprehensive whole genomic and whole transcriptomic analysis as disease biosignatures for cancer diagnosis and treatment.